Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-22

FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Supplemental Application (Endo USA)

View source ↗

Summary

FDA approved a supplemental application for butalbital and acetaminophen (Endo USA), approving changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL AND ACETAMINOPHEN (Butalbital; Acetaminophen)

Snippet

SUPPL AP for BUTALBITAL AND ACETAMINOPHEN (BUTALBITAL AND ACETAMINOPHEN)